G. Dunlevy

Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies

J. Sosabowski, J. Burnet, J. Foster, 2013, PloS one.

Albumin‐Binding Fusion Proteins in the Development of Novel Long‐Acting Therapeutics

Adam Walker, P. Topley, G. Dunlevy, 2013 .

Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon.

Lucy J. Holt, C. Herring, L. Holt, 2010, Protein engineering, design & selection : PEDS.

Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon.

Lucy J. Holt, C. Herring, L. Jespers, 2010, Protein engineering, design & selection : PEDS.